Involuntary movements
55 results
1 - 55
Involuntary movements - Restless legs and akathisia
- Essential tremor
Botulinum toxin type A therapy for blepharospasm New search for studies and content updated (conclusions changed)- Amantadine for dyskinesia in Parkinson's disease Edited (no change to conclusions)
- Aripiprazole for autism spectrum disorders (ASD) New search for studies and content updated (no change to conclusions)
- Miscellaneous treatments for antipsychotic‐induced tardive dyskinesia New search for studies and content updated (no change to conclusions)
- Antipsychotics for acute and chronic pain
- Epilepsy in children
- Lisuride for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
- Physical therapy for Bell's palsy (idiopathic facial paralysis): Cochrane systematic review
- Monoamine oxidase B inhibitors for early Parkinson's disease New search for studies and content updated (no change to conclusions)
- Ropinirole versus bromocriptine for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
- Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease New
- Pergolide versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Lisuride versus bromocriptine for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
- Transcranial direct current stimulation (tDCS) for idiopathic Parkinson's disease New
- Clinical assessment of memory impairment
- Cabergoline versus bromocriptine for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
- Pramipexole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Cabergoline for levodopa‐induced complications in Parkinson's disease Edited (no change to conclusions)
- Tremor
- Fluphenazine (oral) versus atypical antipsychotics for schizophrenia Edited (no change to conclusions)
- Ropinirole for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Fluphenazine (oral) versus placebo for schizophrenia Edited (no change to conclusions)
- Pergolide for levodopa-induced complications in Parkinson's disease: Cochrane systematic review
- Trihexyphenidyl for dystonia in cerebral palsy New
- Vitamin E for antipsychotic‐induced tardive dyskinesia Edited (no change to conclusions)
- Antipsychotics for acute and chronic pain in adults: Cochrane systematic review
- Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia New search for studies and content updated (conclusions changed)
- Surgical interventions for infantile nystagmus syndrome New
- Withdrawal versus continuation of long‐term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia Edited (no change to conclusions)
- Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia Edited (no change to conclusions)
- Schizophrenia
- Rehabilitation of patients with spinal cord injury, and problems associated with such injury